Isocapnic cold air challenge in patients with COPD: Are there any predisposing factors?

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 5, Issue 3, 2008, Pages 171-176

  Kostikas, Konstantinos ^a   Koutsoumbou, Stavroula ^b   Karamanis, Thomas ^c   Papatheodorou, Georgios ^b   Loukides, Stelios ^d,e  

^a UNIVERSITY OF THESSALY   (Greece)

^b 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^c IKA Neas Ionias   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e NONE   (Greece)

Author keywords

Bronchial hyperresponsiveness; Cold air challenge; COPD; Methacholine challenge; Muscarinic receptors

Indexed keywords

METHACHOLINE; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLD AIR; CONTROLLED STUDY; DISEASE PREDISPOSITION; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROVOCATION TEST; VITAL CAPACITY;

AGED; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CAPNOGRAPHY; COLD; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SCOPOLAMINE DERIVATIVES;

EID: 45949110661     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550802093009     Document Type: Article

References (29)

1. Grootendorst DC, Rabe KF. Mechanisms of bronchial hyperreactivity in asthma and COPD. Proc Am Thorac Soc 2004; 1:77-87.
2. Wise RA. The relationship between airways hyperreactivity and COPD. Eur Respir Rev 2002; 12:386-389.
3. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B Di Maria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lotvall J, Magnussen H, Polosa R, Postma DS, Riedler J, ERS Task Force. Indirect airway challenges. Eur Respir J 2003; 21:1050-1068.
4. Ramsdale EH, Roberts RS, Morris MM, Hargreave FE. Differences in repsonsiveness to hyperventilation and methacholine in asthma and chronic bronchitis. Thorax 40:422-426.
5. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984; 39:912-918.
6. Costello RW, Jacoby DB, Fryer AD. Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity. Thorax 1998; 53:613-618.
7. Panning CA, DeBisschop M. Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 2003; 23:183-189.
8. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. Bethesda, National Heart, Lung and Blood Institute, April 2001; Update of the Management Sections, GOLD website (www.goldcopd.com). Date updated: July 2005.
9. American Thoracic Society. Guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med 1998; 161:309-329.
10. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127:1553-1559.
11. Modl M, Eber E, Steinbrugger B, Weinhanl E, Zach MS. Comparing methods for assessing bronchial responsiveness in children: single step cold air challenge,multiple step cold air challenge, and histamine provocation. Eur Respir J 1995; 8:1742-1747.
12. Zervas E, Loukides S, Papatheodorou G, Psathakis K, Tsindiris K, Panagou P, Kalogeropoulos N. Magnesium levels in plasma and in erythrocytes before and after histamine challenge. Eur Respir J 2000; 16:621-625.
13. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152:1107-1136.
14. Pizzichini E, Pizzichini MM, Leigh R, Djukanovic R, Sterk PJ. Safety of sputum induction. Eur Respir J 2002; Suppl 37:9s-18s.
15. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, Cornelissen PJ; Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002; 19(2):209-216.
16. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58:659-664.
17. Anthonisen NR, Lindgren PG, Taskhin DP, Kanner RE, Scanlon PD, Connet JE. Lung Health Study Research Group. Bronchodilator response in Lung Health Study over 11 years. Eur Respir J 2005; 26:45-51.
18. Wise RA, Kanner RE, Lindgren P, Connet JE, Altose MD, Enright PL, Taskhin DP. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD. Chest 2003; 124:449-458.
19. Rutgers SR, Kerstjens HA, Timens W, Tzanakis N, Kauffman HF, Postma DS. Airway inflammation and hyperresponsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease. Clin Exp Allergy 2000; 30:657-662.
20. He JQ, Connett JE, Anthonisen NR, Sanford AJ. Polymorphisms in the IL-13, IL-13RA1 and IL-4RA genes and rate of decline in lung function in smokers. Am J Respir Cell Mol Biol 2003; 28:379-385.
21. Martin JG, Duguet A, Eidelman DH. The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. Eur Respir J 2000; 16:349-354.
22. Wiggs BR, Busken C, Paré P, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive airways disease. Am Rev Respir Dis 1992; 145:1251-1258.
23. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signalling in the pathophysiology of asthma and COPD. Respir Res 2006; 7:73.
24. Fryer AD, Jacoby DB. Muscarinic receptors and control of airway smoothmuscle. Am J Respir Cri Care Med 1998; 158:S154-S160.
25. On LS, Boonyongsunchai P, Webb S, Davies L, Calverley PM, Costello RW. Function of pulmonary neuronal M2 muscarinic receptors in stable Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001; 163:1320-1325.
26. Struckmann N, Schwering S, Wiegand S, Gschnell A, Yamada M, Kummer W, Wess J, Haberberger RV. Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Mol Pharmacol 2003; 64:1444-1451.
27. Kadota H, Kuwahara M, Nishibata R, Mikami H, Tsubone H. Effect of M2 and M3 muscarinic receptors on airway responsiveness to carbachol in bronchial-hypersensitive (BHS) and bronchial-hyposensitive (BHR) guinea pigs. Exp Anim 2001; 50:49-58.
28. Patel HJ, Douglas GJ, Herd CM, Spina D, Giembycz MA, Barnes PJ, Belvisi MG, Page CP. Antigen-induced bronchial hyperresponsiveness in the rabbit is not dependent on M(2)-receptor dysfunction. Pulm Pharmacol Ther 1999; 12:245-255.
29. Tashkin D, Kesten S. Long-termtreatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 2003; 123(5):1441-1449.